Cholestech in $1 million hardware sale for clinical trials:
This article was originally published in Clinica
Executive Summary
Cholestech will provide Parke-Davis and Pfizer enough LDX systems and lipid profile cassettes to supply 1,000 clinicians monitoring lipid levels as part of pharmaceutical trials. In a deal worth in excess of $1 million according to the company, the LDX machines will be donated to the physicians at the end of the trials.